SynthesisApplied clinical informatics2025
Evaluation of the Effectiveness and Safety of Telemedicine in Rheumatoid Arthritis: Meta-analysis.
Synthesis in Applied clinical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to systematically evaluate the effectiveness and safety of telemedicine in improving the corresponding indicators in patients with rheumatoid arthritis (RA).Computer searches of PubMed, Embase, the Cochrane Library, and Web of Science were conducted to collect journal articles on randomized controlled trials and clinical trials of telemedicine interventions for RA. A meta-analysis was performed using the risk-of-bias assessment tool Reedman 5.4 software from the Cochrane Handbook.The systematic assessment includes 17 studies totaling 2,324 patients, with a middling level of quality across the included research. The findings of this study demonstrated that individuals with RA had better treatment efficiency in C-reactive protein than those in the control group (mean difference [MD] = - 21.17, 95% confidence interval [CI] = - 49.57 to 7.23;
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.